Meyka Pro banner
XWELL, Inc.

XWELL, Inc. Fundamental Analysis (NASDAQ: XWEL)

XWELNASDAQ
HealthcareMedical - Care Facilities
$1.04
$0.11(11.82%)
U.S. Market opens in 64h 7m

XWELL, Inc. Fundamental Analysis (NASDAQ: XWEL)

XWELL, Inc. (NASDAQ: XWEL) shows weak financial fundamentals with a PE ratio of -0.18, profit margin of -82.81%, and ROE of 3.18%. The company generates $0.0B in annual revenue with weak year-over-year growth of -13.83%.

Key Strengths

Cash Position142.55%
PEG Ratio0.00
Current Ratio2.27

Areas of Concern

ROE3.18%
Operating Margin-24.14%
We analyze XWEL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -5.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-5.1/100

We analyze XWEL's fundamental strength across five key dimensions:

Efficiency Score

Weak

XWEL struggles to generate sufficient returns from assets.

ROA > 10%
-1.14%

Valuation Score

Excellent

XWEL trades at attractive valuation levels.

PE < 25
-0.18
PEG Ratio < 2
0.00

Growth Score

Weak

XWEL faces weak or negative growth trends.

Revenue Growth > 5%
-13.83%
EPS Growth > 10%
-38.80%

Financial Health Score

Excellent

XWEL maintains a strong and stable balance sheet.

Debt/Equity < 1
-3.93
Current Ratio > 1
2.27

Profitability Score

Weak

XWEL struggles to sustain strong margins.

ROE > 15%
3.18%
Net Margin ≥ 15%
-82.81%
Positive Free Cash Flow
No

Key Financial Metrics

Is XWEL Expensive or Cheap?

P/E Ratio

XWEL trades at -0.18 times earnings. This suggests potential undervaluation.

-0.18

PEG Ratio

When adjusting for growth, XWEL's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values XWELL, Inc. at -4.07 times its book value. This may indicate undervaluation.

-4.07

EV/EBITDA

Enterprise value stands at -0.56 times EBITDA. This is generally considered low.

-0.56

How Well Does XWEL Make Money?

Net Profit Margin

For every $100 in sales, XWELL, Inc. keeps $-82.81 as profit after all expenses.

-82.81%

Operating Margin

Core operations generate -24.14 in profit for every $100 in revenue, before interest and taxes.

-24.14%

ROE

Management delivers $3.18 in profit for every $100 of shareholder equity.

3.18%

ROA

XWELL, Inc. generates $-1.14 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.14%

Following the Money - Real Cash Generation

Operating Cash Flow

XWELL, Inc. generates limited operating cash flow of $-6.74M, signaling weaker underlying cash strength.

$-6.74M

Free Cash Flow

XWELL, Inc. generates weak or negative free cash flow of $-8.77M, restricting financial flexibility.

$-8.77M

FCF Per Share

Each share generates $-1.11 in free cash annually.

$-1.11

FCF Yield

XWEL converts -1.21% of its market value into free cash.

-1.21%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.18

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.004

vs 25 benchmark

P/B Ratio

Price to book value ratio

-4.07

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.27

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-3.93

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.27

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

3.18

vs 25 benchmark

ROA

Return on assets percentage

-1.14

vs 25 benchmark

ROCE

Return on capital employed

-0.49

vs 25 benchmark

How XWEL Stacks Against Its Sector Peers

MetricXWEL ValueSector AveragePerformance
P/E Ratio-0.1831.19 Better (Cheaper)
ROE317.52%447.00% Weak
Net Margin-82.81%21592.00% Weak
Debt/Equity-3.930.54 Strong (Low Leverage)
Current Ratio2.275.66 Strong Liquidity
ROA-114.10%-52.00% (disorted) Weak

XWEL outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews XWELL, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

129.69%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

87.62%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

77.03%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ